Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $98.0300 (0.34%) ($97.4500 - $98.9200) on Thu. Jul. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.62% (three month average) | RSI | 47 | Latest Price | $98.0300(0.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(50%) SPLV(38%) VYM(36%) DIA(34%) XLP(34%) | Factors Impacting ABBV price | ABBV will decline at least -0.81% in a week (0% probabilities). VIXM(-24%) UUP(-9%) VXX(-6%) TLT(-3%) XLC(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.81% (StdDev 1.62%) | Hourly BBV | -0 () | Intraday Trend | -0.2% | | | |
|
Inflection Point | Yes | Resistance Level | $98.47 | 5 Day Moving Average | $98.7(-0.68%) | 10 Day Moving Average | $98.75(-0.73%) | 20 Day Moving Average | $98.47(-0.45%) | To recent high | -2.8% | To recent low | 19.8% | Market Cap | $172.953b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |